A 58-year-old with new T2D has A1C 9.2%, no catabolic symptoms. eGFR 70. According to ADA 2025, which initial pharmacologic approach is preferred?...

Question

A 58-year-old with new T2D has A1C 9.2%, no catabolic symptoms. eGFR 70. According to ADA 2025, which initial pharmacologic approach is preferred?

Accepted Answer

Metformin monotherapy only

Answer

Dual therapy with metformin plus another agent (e.g. GLP-1 RA or SGLT2 inhibitor)

Answer

Insulin

Answer

Sulfonylurea monotherapy

Answer

No medications; lifestyle only

"endocrinology" MCQ (SBA): Type 2 Diabetes Mellitus